Cargando…
Immunohistochemical markers to diagnose primary squamous cell carcinoma of the lung: a meta-analysis of diagnostic test accuracy
BACKGROUND: Inconsistent diagnostic test accuracies of immunohistological staining for squamous cell carcinoma (SQC) of the lung have been frequently reported. There have been few meta-analyses of the diagnostic accuracies of the immunohistochemical markers. METHODS: A systematic review and meta-ana...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814972/ https://www.ncbi.nlm.nih.gov/pubmed/35126682 http://dx.doi.org/10.1177/17588359211065152 |
_version_ | 1784645188564549632 |
---|---|
author | Chen, Hao Katakura, Seigo Horita, Nobuyuki Namkoong, Ho Kato, Ikuma Hara, Yu Kobayashi, Nobuaki Fujii, Satoshi Kaneko, Takeshi |
author_facet | Chen, Hao Katakura, Seigo Horita, Nobuyuki Namkoong, Ho Kato, Ikuma Hara, Yu Kobayashi, Nobuaki Fujii, Satoshi Kaneko, Takeshi |
author_sort | Chen, Hao |
collection | PubMed |
description | BACKGROUND: Inconsistent diagnostic test accuracies of immunohistological staining for squamous cell carcinoma (SQC) of the lung have been frequently reported. There have been few meta-analyses of the diagnostic accuracies of the immunohistochemical markers. METHODS: A systematic review and meta-analysis were performed following standard guidelines for systematic reviews of diagnostic test accuracy. Immunohistochemical markers (p40, p63, CK5/6, and DSC3) were evaluated as index tests for SQC. The diagnostic odds ratio (DOR) was obtained by the DerSimonian–Laird variate model. Summary estimates of sensitivity and specificity were calculated using a bivariate model. The protocol registration ID is UMIN000041664. RESULTS: The meta-analysis included 85 of the 1353 first-screened articles. The total number of patients was 17,893, which consisted 6151 SQC cases and 11,742 non-squamous non-small-cell lung cancer cases. The DOR was better for p40 (377, 95% confidence interval (CI) = 213–644, I(2) = 0%) than for CK5/6 (120, 95% CI = 78–184, I(2) = 2.5%), p63 (70, 95% CI = 55–88, I(2) = 9.1%), and DSC3 (94, 95% CI = 35–250, I(2) = 3.7%). Summary estimates of sensitivity and specificity were followings: p40 sensitivity 0.92 (95% CI = 0.89–0.95), specificity 0.94 (95% CI = 0.93–0.96); p63 sensitivity 0.92 (95% CI = 0.90–0.94), specificity 0.83 (95% CI = 0.80–0.86); CK5/6 sensitivity 0.90 (95% CI = 0.87–0.93), specificity 0.91 (95% CI = 0.89–0.93); DSC3 sensitivity 0.81 (95% CI = 0.73–0.88), and specificity 0.95 (95% CI = 0.85–0.98). CONCLUSION: P40 had the best DOR to diagnose SQC in non-small-cell lung carcinoma. Despite its lower sensitivity, DSC3 had the best specificity among the four markers and might be useful to rule-in the diagnosis of SQC. |
format | Online Article Text |
id | pubmed-8814972 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-88149722022-02-05 Immunohistochemical markers to diagnose primary squamous cell carcinoma of the lung: a meta-analysis of diagnostic test accuracy Chen, Hao Katakura, Seigo Horita, Nobuyuki Namkoong, Ho Kato, Ikuma Hara, Yu Kobayashi, Nobuaki Fujii, Satoshi Kaneko, Takeshi Ther Adv Med Oncol Review BACKGROUND: Inconsistent diagnostic test accuracies of immunohistological staining for squamous cell carcinoma (SQC) of the lung have been frequently reported. There have been few meta-analyses of the diagnostic accuracies of the immunohistochemical markers. METHODS: A systematic review and meta-analysis were performed following standard guidelines for systematic reviews of diagnostic test accuracy. Immunohistochemical markers (p40, p63, CK5/6, and DSC3) were evaluated as index tests for SQC. The diagnostic odds ratio (DOR) was obtained by the DerSimonian–Laird variate model. Summary estimates of sensitivity and specificity were calculated using a bivariate model. The protocol registration ID is UMIN000041664. RESULTS: The meta-analysis included 85 of the 1353 first-screened articles. The total number of patients was 17,893, which consisted 6151 SQC cases and 11,742 non-squamous non-small-cell lung cancer cases. The DOR was better for p40 (377, 95% confidence interval (CI) = 213–644, I(2) = 0%) than for CK5/6 (120, 95% CI = 78–184, I(2) = 2.5%), p63 (70, 95% CI = 55–88, I(2) = 9.1%), and DSC3 (94, 95% CI = 35–250, I(2) = 3.7%). Summary estimates of sensitivity and specificity were followings: p40 sensitivity 0.92 (95% CI = 0.89–0.95), specificity 0.94 (95% CI = 0.93–0.96); p63 sensitivity 0.92 (95% CI = 0.90–0.94), specificity 0.83 (95% CI = 0.80–0.86); CK5/6 sensitivity 0.90 (95% CI = 0.87–0.93), specificity 0.91 (95% CI = 0.89–0.93); DSC3 sensitivity 0.81 (95% CI = 0.73–0.88), and specificity 0.95 (95% CI = 0.85–0.98). CONCLUSION: P40 had the best DOR to diagnose SQC in non-small-cell lung carcinoma. Despite its lower sensitivity, DSC3 had the best specificity among the four markers and might be useful to rule-in the diagnosis of SQC. SAGE Publications 2022-02-02 /pmc/articles/PMC8814972/ /pubmed/35126682 http://dx.doi.org/10.1177/17588359211065152 Text en © The Author(s), 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Review Chen, Hao Katakura, Seigo Horita, Nobuyuki Namkoong, Ho Kato, Ikuma Hara, Yu Kobayashi, Nobuaki Fujii, Satoshi Kaneko, Takeshi Immunohistochemical markers to diagnose primary squamous cell carcinoma of the lung: a meta-analysis of diagnostic test accuracy |
title | Immunohistochemical markers to diagnose primary squamous cell carcinoma of the lung: a meta-analysis of diagnostic test accuracy |
title_full | Immunohistochemical markers to diagnose primary squamous cell carcinoma of the lung: a meta-analysis of diagnostic test accuracy |
title_fullStr | Immunohistochemical markers to diagnose primary squamous cell carcinoma of the lung: a meta-analysis of diagnostic test accuracy |
title_full_unstemmed | Immunohistochemical markers to diagnose primary squamous cell carcinoma of the lung: a meta-analysis of diagnostic test accuracy |
title_short | Immunohistochemical markers to diagnose primary squamous cell carcinoma of the lung: a meta-analysis of diagnostic test accuracy |
title_sort | immunohistochemical markers to diagnose primary squamous cell carcinoma of the lung: a meta-analysis of diagnostic test accuracy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814972/ https://www.ncbi.nlm.nih.gov/pubmed/35126682 http://dx.doi.org/10.1177/17588359211065152 |
work_keys_str_mv | AT chenhao immunohistochemicalmarkerstodiagnoseprimarysquamouscellcarcinomaofthelungametaanalysisofdiagnostictestaccuracy AT katakuraseigo immunohistochemicalmarkerstodiagnoseprimarysquamouscellcarcinomaofthelungametaanalysisofdiagnostictestaccuracy AT horitanobuyuki immunohistochemicalmarkerstodiagnoseprimarysquamouscellcarcinomaofthelungametaanalysisofdiagnostictestaccuracy AT namkoongho immunohistochemicalmarkerstodiagnoseprimarysquamouscellcarcinomaofthelungametaanalysisofdiagnostictestaccuracy AT katoikuma immunohistochemicalmarkerstodiagnoseprimarysquamouscellcarcinomaofthelungametaanalysisofdiagnostictestaccuracy AT harayu immunohistochemicalmarkerstodiagnoseprimarysquamouscellcarcinomaofthelungametaanalysisofdiagnostictestaccuracy AT kobayashinobuaki immunohistochemicalmarkerstodiagnoseprimarysquamouscellcarcinomaofthelungametaanalysisofdiagnostictestaccuracy AT fujiisatoshi immunohistochemicalmarkerstodiagnoseprimarysquamouscellcarcinomaofthelungametaanalysisofdiagnostictestaccuracy AT kanekotakeshi immunohistochemicalmarkerstodiagnoseprimarysquamouscellcarcinomaofthelungametaanalysisofdiagnostictestaccuracy |